- Release Date: 11/10/18 08:27
- Summary: Positive Phase 1 Results of Phase 1 Study - LOXL2 Inhibitor
- Price Sensitive: Yes
- Download Document 117.56KB
- Forums
- ASX - By Stock
- SNT
- Ann: Positive Phase 1 Results of Phase 1 Study - LOXL2 Inhibitor
SNT
syntara limited
Add to My Watchlist
3.45%
!
2.8¢

Ann: Positive Phase 1 Results of Phase 1 Study - LOXL2 Inhibitor
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.8¢ |
Change
-0.001(3.45%) |
Mkt cap ! $45.57M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 2.8¢ | $305.8K | 10.50M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 5470156 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 138000 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 5267686 | 0.028 |
36 | 4264385 | 0.027 |
15 | 804346 | 0.026 |
19 | 2305922 | 0.025 |
3 | 812666 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 138000 | 4 |
0.030 | 2517200 | 8 |
0.031 | 1390000 | 7 |
0.032 | 1454200 | 7 |
0.033 | 450000 | 3 |
Last trade - 16.10pm 13/08/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |